What to expect from PEGS Europe 2023: Day 3
Drug Discovery World
NOVEMBER 13, 2023
Thereafter, there will be five presentations as follows: Keenan Taylor, PhD, Senior Scientist, AbbVie, on: ‘GPCR production strategies to enable antibody discovery and characterisation’. Dorien De Vlieger, PhD, Scientist, Molecular Engineering, Confo Therapeutics, on: ‘ConfoBodies for parallel discovery of GPCR agonistic antibodies’.
59 
Let's personalize your content